Thinking of joining a study?

Register your interest

Become a volunteer?

Clinical trials

3365 results

Sort By:

The Study on the Effect of Different Administration Methods of Simethicone in Reducing Bubbles During Bowel Preparation

Study ID: NCT06919120
Start Date: 2025-06-01
End Date: 2027-10-31
Study Type

Interventional

Study Phase

Phase4

No. of Participants

3

Intervention / Treatment

Simethicone is mixed into the final packet of compound polyethylene glycol electrolyte powder

Take simethicone separately

Sponsor

The Fourth Affiliated Hospital of Zhejiang University School of Medicine

Source: clinicaltrials.gov

Share:
Add to list

A Dose-finding Study of JMKX003142 in Treatment of Cardiac Edema

Study ID: NCT06949020
Start Date: 2025-06-01
End Date: 2027-05-31
Study Type

Interventional

Study Phase

Phase2

No. of Participants

160

Intervention / Treatment

JMKX003142 Injection

JMKX003142 Injection

JMKX003142 Injection

JMKX003142 placebo

Sponsor

Jmincare

Source: clinicaltrials.gov

Share:
Add to list

Cladribine Tablets as an Exit Therapy Strategy

Study ID: NCT06887426
Start Date: 2025-06
End Date: 2025-12
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

450

Intervention / Treatment

Cladribine

Sponsor

University Hospital, Strasbourg, France

Source: clinicaltrials.gov

Share:
Add to list

Improved Successful Retrieval Rate of HydroMARK Plus Breast Biopsy Site Marker in Comparison to HydroMARK as Well as Improved Surgeon Satisfaction

Study ID: NCT06294574
Start Date: 2025-06
End Date: 2027-12
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

150

Intervention / Treatment

HydroMARK Plus Clip

Sponsor

University of Alabama at Birmingham

Source: clinicaltrials.gov

Share:
Add to list

Influence of Lidocaine Infusion on Motor Evoked Potential Thresholds

Study ID: NCT06792474
Start Date: 2025-08
End Date: 2026-08
Study Type

Interventional

Study Phase

Phase4

No. of Participants

44

Intervention / Treatment

Lidocaine in Saline

Normal saline

Sponsor

Dartmouth-Hitchcock Medical Center

Source: clinicaltrials.gov

Share:
Add to list

Trial of Sequential Medications AfteR TNFi Failure in Juvenile Idiopathic Arthritis

Study ID: NCT06654882
Start Date: 2025-08
End Date: 2026-12
Study Type

Interventional

Study Phase

Phase3

No. of Participants

400

Intervention / Treatment

TNFi (Tumor Necrosis Factor inhibitor) medication

Abatacept

Tocilizumab

Tofacitinib

Sponsor

Duke University

Source: clinicaltrials.gov

Share:
Add to list

Implementation of Tobacco Cessation Programming at Community Behavioral Health Sites

Study ID: NCT06837220
Start Date: 2025-07
End Date: 2027-01
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

24

Intervention / Treatment

Enhanced Courage to Quit

Sponsor

University of Chicago

Source: clinicaltrials.gov

Share:
Add to list

RELIVE (Randomized Evaluation of Less Invasive Ventricular Enhancement) Trial

Study ID: NCT06813820
Start Date: 2025-08
End Date: 2032-08
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

135

Intervention / Treatment

Relive system

Sponsor

BioVentrix

Source: clinicaltrials.gov

Share:
Add to list

Exercise in Triple- Negative Breast Cancer

Study ID: NCT06672120
Start Date: 2025-12-01
End Date: 2027-12-31
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

120

Intervention / Treatment

Exercise training

Sponsor

Technical University of Munich

Source: clinicaltrials.gov

Share:
Add to list

Biomarker Directed Trial of Temozolomide and PARP Inhibition in Relapsed SCLC

Study ID: NCT06681220
Start Date: 2025-06-01
End Date: 2030-12-31
Study Type

Interventional

Study Phase

Phase2

No. of Participants

152

Intervention / Treatment

PARP inhibitor/Temozolomide

Lurbinectedin

Sponsor

VA Office of Research and Development

Source: clinicaltrials.gov

Share:
Add to list